Literature DB >> 25880031

Chlamydia (uncomplicated, genital).

Megan Crofts1, Paddy Horner.   

Abstract

INTRODUCTION: Genital chlamydia is the most commonly reported bacterial sexually transmitted infection in developed countries. The majority of infections affect young adults under the age of 25 years. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of antibiotic treatment for men and non-pregnant women with uncomplicated genital chlamydial infection? What are the effects of antibiotic treatment for pregnant women with uncomplicated genital chlamydial infection? We searched: Medline, Embase, The Cochrane Library, and other important databases up to February 2014 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 26 studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions - for men and non-pregnant women: antibiotics (single-dose) and antibiotics (multiple-dose regimens); for pregnant women: antibiotics (single-dose), erythromycin or amoxicillin (multiple-dose regimens), and clindamycin (multiple-dose regimens).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25880031      PMCID: PMC4399547     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  47 in total

1.  Update on lymphogranuloma venereum in the United Kingdom.

Authors:  Heather Jebbari; Sarah Alexander; Helen Ward; Barry Evans; Maria Solomou; Alicia Thornton; Gillian Dean; John White; Patrick French; Catherine Ison
Journal:  Sex Transm Infect       Date:  2007-06-25       Impact factor: 3.519

2.  2013 UK National Guideline for the management of lymphogranuloma venereum: Clinical Effectiveness Group of the British Association for Sexual Health and HIV (CEG/BASHH) Guideline development group.

Authors:  John White; Nigel O'Farrell; David Daniels
Journal:  Int J STD AIDS       Date:  2013-07-25       Impact factor: 1.359

3.  Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.

Authors:  Benjamin Bar-Oz; Orna Diav-Citrin; Svetlana Shechtman; Rotem Tellem; Judith Arnon; Igor Francetic; Matitiahu Berkovitch; Asher Ornoy
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2008-08-29       Impact factor: 2.435

Review 4.  Interventions for treating genital chlamydia trachomatis infection in pregnancy.

Authors:  P Brocklehurst; G Rooney
Journal:  Cochrane Database Syst Rev       Date:  2000

5.  Minocycline compared with doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis.

Authors:  B Romanowski; H Talbot; M Stadnyk; P Kowalchuk; W R Bowie
Journal:  Ann Intern Med       Date:  1993-07-01       Impact factor: 25.391

6.  The relationship of Chlamydia trachomatis infection and male infertility.

Authors:  G A Greendale; S T Haas; K Holbrook; B Walsh; J Schachter; R S Phillips
Journal:  Am J Public Health       Date:  1993-07       Impact factor: 9.308

Review 7.  Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature.

Authors:  Christina B Hosenfeld; Kimberly A Workowski; Stuart Berman; Akbar Zaidi; Jeri Dyson; Debra Mosure; Gail Bolan; Heidi M Bauer
Journal:  Sex Transm Dis       Date:  2009-08       Impact factor: 2.830

8.  Early repeat Chlamydia trachomatis and Neisseria gonorrhoeae infections among heterosexual men.

Authors:  Patricia J Kissinger; Kathleen Reilly; Stephanie N Taylor; Jami S Leichliter; Susan Rosenthal; David H Martin
Journal:  Sex Transm Dis       Date:  2009-08       Impact factor: 2.830

9.  Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations.

Authors:  William O Cooper; Sonia Hernandez-Diaz; Patrick G Arbogast; Judith A Dudley; Shannon M Dyer; Patricia S Gideon; Kathleen S Hall; Lisa A Kaltenbach; Wayne A Ray
Journal:  Paediatr Perinat Epidemiol       Date:  2009-01       Impact factor: 3.980

10.  Roxithromycin compared with erythromycin against genitourinary chlamydial infections.

Authors:  A M Worm; G Hoff; S Kroon; C S Petersen; J J Christensen
Journal:  Genitourin Med       Date:  1989-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.